Biotechnology

About Conference

BioTechnology-2024  invites the participants from all over the world to attend “28^th Global Congress on Biotechnology” during October 24-25, 2024 Zurich, Switzerland. Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. The Theme of this conference is "Innovations in Biotechnology: Shaping the Future of Science and Medicine."  

Innovative Technologies Are A Main Focus In Bio Technology. The Keynote Speakers And Inspiring Introductions At This Conference Will Offer A Global Forum For Discussion Of Current And Upcoming Challenges In 28^th Global Congress on Biotechnology.

Biotechnology 2024 includes -

• Keynote presentations
• Plenary talks
• Speaker presentations
• Young Research Forum
• Poster presentations
• Exhibitions

Why to attend?

Attending a biotechnology conference offers a unique opportunity to network with experts, researchers, and industry leaders in the field. It provides a platform to stay updated on the latest advancements, trends, and best practices in biotechnology. The conference sessions feature presentations, workshops, and panel discussions covering a wide range of topics, from genomics and bioinformatics to drug discovery and agricultural biotechnology. It fosters collaboration and partnership-building, facilitating potential research collaborations, funding opportunities, and business connections. By attending, participants gain insights into cutting-edge technologies and methodologies, enhancing their professional development and skillset. The exposure to new ideas and innovations sparks creativity and inspires innovative solutions to challenges in biotechnology. Conferences also offer access to resources, such as exhibitor booths showcasing products, services, and publications relevant to the industry. Additionally, participation in conferences can enhance professional reputation, visibility, and career advancement opportunities within the biotechnology community. Overall, attending a biotechnology conference is a rewarding experience that fosters learning, collaboration, and growth in the dynamic field of biotechnology.

Sessions & Tracks

1. Biopharmaceuticals

Biopharmaceuticals, integral to biotechnology, encompass a diverse array of therapeutic agents derived from living organisms. They include proteins, antibodies, vaccines, and gene therapies, revolutionizing medical treatment approaches. Biotechnological processes, such as genetic engineering and cell culture, enable the production of these advanced therapies. These drugs offer targeted treatments, addressing specific molecular targets with high efficacy and often fewer side effects. Monoclonal antibodies, a prominent example, are widely used for cancer therapy and autoimmune disorders. The development of biopharmaceuticals requires stringent research, clinical trials, and regulatory approval, ensuring safety and efficacy. They represent a rapidly growing sector of the pharmaceutical industry, driving innovation and personalized medicine. Biopharmaceuticals hold immense potential for addressing unmet medical needs and improving patient outcomes globally.

2. Covid-19 Drug Development

Covid-19 drug development in biotechnology involves leveraging cutting-edge technologies to expedite the discovery, development, and production of treatments for the virus. Biotech companies are utilizing platforms like mRNA technology, monoclonal antibodies, and antiviral drugs to target the SARS-CoV-2 virus. Collaborations between academia, industry, and government entities facilitate rapid research and clinical trials. Adaptive trial designs and real-time data analysis enable swift decision-making and regulatory approval processes. Vaccine development, including mRNA vaccines, has seen unprecedented speed and efficacy in combating the pandemic. Biotech firms are also exploring innovative approaches like repurposing existing drugs and developing novel therapeutics to address Covid-19 symptoms and complications. The global response to Covid-19 showcases the pivotal role of biotechnology in addressing public health emergencies and accelerating medical breakthroughs. With ongoing research and collaboration, biotechnology continues to drive progress in mitigating the impact of the pandemic and preventing future outbreaks.

3. Nanoparticles in Biopharmaceuticals

In biopharmaceuticals, nanoparticles can be used to encapsulate drugs or biologics, protecting them from degradation and improving their stability. They can also be used to modify the pharmacokinetics of a drug, allowing for sustained release and longer-lasting effects.Nanoparticles can be made from a variety of materials, including lipids, polymers, and metals. They can be engineered to have specific properties, such as biodegradability, biocompatibility, and targeting ability.Overall, the use of nanoparticles in biopharmaceuticals is a rapidly growing field that has the potential to revolutionize drug delivery and improve patient outcomes. However, there are still challenges to be addressed, including safety concerns and regulatory issues.

4. Agriculture Biotechnology

Agricultural biotechnology encompasses the application of scientific techniques to improve crop yield, quality, and resilience. Genetic engineering enables the development of genetically modified organisms (GMOs) with desired traits, such as resistance to pests, diseases, and environmental stresses. Biotech crops, including insect-resistant and herbicide-tolerant varieties, offer sustainable solutions to agricultural challenges. Precision breeding techniques, like genome editing, allow for targeted modifications to crop genomes, accelerating trait development. Biotechnology enhances food security by increasing crop productivity and reducing losses due to pests and diseases. Biotech innovations also contribute to environmental sustainability by reducing the need for chemical inputs and conserving natural resources. The adoption of biotech crops has grown globally, benefiting farmers, consumers, and the environment. Continued research in agricultural biotechnology holds promise for addressing future challenges, such as climate change and population growth. Ethical considerations and regulatory frameworks guide the responsible use of biotechnology in agriculture, ensuring safety and environmental stewardship. Overall, agricultural biotechnology plays a vital role in advancing sustainable farming practices and ensuring global food security.

5. Advances in Biotech Manufacturing

Recent years have seen significant advancements in biotech manufacturing, including the development of new technologies that have improved the efficiency, scalability, and cost-effectiveness of biologic drug production. Continuous manufacturing, single-use systems, and new expression systems, such as cell-free systems and synthetic biology, have all contributed to the production of complex biologics that were previously difficult to manufacture. Additionally, advancements in process analytics and control have improved the quality and consistency of biologic drug production, making it more reliable and reproducible. These advancements have transformed biotech manufacturing, making it more efficient, cost-effective, and capable of producing the next generation of life-saving biologic drugs.

6. Evolution of drugs and Drug Labs

Drug evolution is a unique idea that is put out to create chemical libraries with a high likelihood of discovering medications or drug candidates. Chemical evolution replaces biological evolution as a result. In this study, we present "hybridization" drug evolution, which in biological evolution is comparable to sexual recombination of parental genomes. No drug development can take place without the hybridization, which essentially shuffles the components of the parent medicines and ought to drug(s). We created 16 compounds by combining the two parent medications, benzocaine and metoclopramide, with four other known pharmaceuticals and two more molecules with recognised therapeutic properties. The exceptionally large number of medications and drug prospects in the library raises hopes that the final eight chemicals will provide new pharmaceuticals or drug candidates.

7. Drug Regulations & Quality Assurance

The technique of testing, developing and advertising of drug treatments has to regulated to defend the hobbies of the public. Major regulatory our bodies consist of the Food & Drug Administration (FDA) in the US and the European Medicines Agency (EMA) in Europe. The purpose of pharmaceutical first-rate warranty is to make certain that the medication being synthetic will offer the desired impact to the affected person. Quality guarantee also guarantees that there are not any contaminants gifts and that the medications will meet satisfactory requirements and all applicable policies.

8. Clinical Trials and Clinical Research

Clinical trials are a sort of research that research new tests and treatments and evaluates their effects on human health effects. People volunteer to take part in scientific trials to test scientific interventions consisting of pills, cells and other organic merchandise, surgical strategies, radiological methods, gadgets, behavioural treatments and preventive care. Clinical trials are carefully designed, reviewed and finished, and want to be permitted before they are able to begin. People of all ages can participate in clinical trials, such as children. While preclinical research answers primary questions on a drug’s protection, it isn't always an alternative choice to research of approaches the drug will interact with the human body. “Clinical research” refers to studies, or trials, which can be accomplished in people. As the builders design the medical study, they'll don't forget what they want to perform for every of the unique Clinical Research Phases and begin the Investigational New Drug Process (IND), a procedure they must undergo earlier than clinical research starts.

9. Cosmetic Biotechnology

Biotechnology has had an effect on cosmetics in numerous methods. Cosmetics groups use biotechnology to find out, increase, and bring components of cosmetic formulations and to assess the pastime of those components at the skin, specially, how they could have an effect on the modifications associated with ageing. Biotechnology makes use of microorganisms and/or enzymes to gain particular products through fermentative approaches and/or genetic engineering strategies. Examples of these products are energetic elements, which include hyaluronic acid, kojic acid, resveratrol, and some enzymes, which are utilized in skin anti-ageing merchandise. In addition, certain growth elements, algae, stem cells, and peptides had been protected in cosmetics and aesthetic medicines. Thus, biotechnology, cosmetics and aesthetic medicines are now closely related, via the production of first-rate energetic ingredients, which can be more powerful and more secure.

10. Biotechnology for Nutrition and Food Sciences

Biotechnology encompasses the simple and applied sciences of living structures and their engineering factors required to make the most their bioprocesses to carry products to the marketplace vicinity. While knowledge of bioprocess era has rapidly advanced in latest years, man has been working towards biotechnology considering that prehistoric instances. Today biotechnology has moved beyond neighbourhood manufacturing of alcohol or fermented meals to the production of bio-substances and delicate merchandise and it has a fantastic potential for similarly increasing meals production, improving meals raw substances and producing components so that it will enhance human health. It have to be understood that biotechnology is a set of techniques a number of which may involve genetic engineering for the production of genetically changed meals (GMO).

11. Food Biotechnology

Food technology is a subfield of food science that deals with the invention, production, preservation, and quality control of food items. Early studies in food technology were primarily concerned with food preservation. The invention of the canning method by Nicolas Appert in 1810 was a pivotal moment. However, canning has had a significant influence on food preservation methods even if the process wasn't known as canning at the time and Apart didn't fully understand the underlying principle of his method. The first attempt to apply scientific knowledge to food handling was made by Louis Pasteur in 1864 with his study on the deterioration of wine and his explanation of how to prevent deterioration. Pasteur conducted study on the creation of alcohol, vinegar, wines, and beer as well as the souring of milk in addition to his studies on wine spoilage.

12. Genetic Engineering

Genetic engineering is the manipulation of an organism's DNA to create new traits or characteristics. This process involves the use of biotechnology tools like CRISPR-Cas9 to alter the genetic material of an organism, allowing for the creation of new organisms with specific desirable traits or for the modification of existing organisms to better suit their environment or serve a specific purpose. Genetic engineering has many applications, including in medicine, agriculture, and biotechnology. However, there are also ethical and environmental concerns associated with the use of genetic engineering, which require careful consideration and regulation.

13. Industrial and Environmental Biotechnology

Environmental biotechnology, on the other hand, is the application of biotechnology to solve environmental problems, such as pollution, waste management, and resource conservation. This involves the use of microorganisms to remove or degrade pollutants from the environment, as well as the development of bioremediation technologies to clean up contaminated sites. Environmental biotechnology also includes the use of biotechnology to develop sustainable agricultural practices and to conserve biodiversity.

Both industrial and environmental biotechnology have the potential to contribute to sustainable development by reducing our dependence on fossil fuels, minimizing waste, and protecting the environment. However, there are also ethical and regulatory issues associated with the use of biotechnology, which need to be carefully considered and managed.

14. Biotechnology in Dentistry

Advances in biotechnology have supplied surgeons an alternative to help accelerate alveolar bone regeneration and beautify gentle tissue boom the use of concentrated blood serum. By utiltizing a small extent of Platlet Rich Plasma (i-PRF) obtained from the sufferers personal blood medical doctors can now add it to extraction web sites and bone graft material to yield a 3 dimensional biocompatible fibrin matrix that releases a host of clearly occuring boom factors which contrinute to rapid restoration and bone regeneration. Among these elements are PDGF, TGF-b, IGF-I, and VEGF. Platelet Derived Growth Factor, Insulin associated Growth Factor-I, Transforming Growth Factor-b, and Vascular Endothelial growth Factor are the primary factors concerned. Once the plasma fraction is activated they play a essential position in revascularization and bone tissue regeneration. They paintings to induce mitogenic and proliferative interest of osteoprogenitor cells and endothelial cells as a result enhancing healing time and accelerating implant osseointegration. Together they paintings to growth bone remineralization, produce collagen, and promote blood vessel boom.

15. Genetics and Molecular Biotechnology

Molecular Biology and Genetics are searching for to recognize how the molecules that make up cells decide the conduct of living matters. Biologists use molecular and genetic tools to examine the feature of these molecules in the complex milieu of the living cellular. Groups in our branch are the use of these procedures to examine a huge style of questions, including the essential processes of transcription and translation, mechanisms of world gene manipulate which include signal transduction pathways, the function of the visual and olfactory systems, and the character of genetic range in herbal populations and how that impacts their evolution, amongst others. The structures under have a look at cowl the variety of model organisms (bacteria, yeast, slime molds, worms, fruit flies, zebrafish, and mice) though the outcomes of those research relate without delay or in a roundabout way to human health.

Market Analysis

The global biotechnology market was valued at USD 1452.30 billion in 2023 and is expected to grow at a CAGR of 13.4% during the forecast period.

Government initiatives promoting regulatory modernization, streamlined approval processes, and enhanced reimbursement policies, along with standardized clinical studies, propel the market. The rise of personalized medicine and the expanding portfolio of orphan drug formulations create opportunities for biotechnology applications, attracting emerging innovative companies and contributing to market revenue growth.

The market experiences growth due to rising demand for biotechnology tools in agricultural applications, such as micro-propagation, molecular breeding, tissue culturing, conventional plant breeding, and the development of genetically modified crops. The increasing popularity of genetically modified crops, herbicide-tolerant, and insect-resistant seeds further contributes to market expansion. The adoption of tissue culture technology for producing novel rice variants and disease- and pest-free banana varieties in South Asia and Africa, along with its use in cloning disease-free and nutritious plant varieties, drives the application of biotechnology in agriculture.

A robust clinical trial pipeline and available funding opportunities in tissue engineering and regeneration technologies propel the market. According to the Alliance for Regenerative Medicine, companies involved in cell and gene therapies received over USD 23.1 billion in global investments in 2021, marking a 16% increase from the previous year's total of USD 19.9 billion. The clinical success of key gene therapy players in 2021, such as positive outcomes from Intellia Therapeutics and Regeneron's in vivo CRISPR treatment for transthyretin amyloidosis, has a substantial impact on market growth.The life sciences and healthcare sectors are witnessing extensive utilization of fermentation technology, contributing significantly to market growth. Innovations and enhancements in traditional bioreactors, including the introduction of simplified and vortex bioreactors, have resulted in advancements and increased adoption of fermentation technology. Moreover, improvements in vortex bioreactors for wastewater processing enhance operational feasibility. These modifications and advancements in fermentation technology are anticipated to drive accelerated market growth in the foreseeable future.

By Technology Analysis

The DNA Sequencing segment held the largest revenue share in 2022.The decrease in sequencing costs and the increased adoption of advanced DNA sequencing techniques are credited for the surge. Government funding in genetic research has facilitated the expanded applications of sequencing, leading to a deeper understanding of diseases. For instance, in May 2021, the University of Pittsburgh Graduate School of Public Health and Washington University School of Medicine in St. Louis received a USD 10.7 million NIH grant for the exploration of the genetic foundation of Alzheimer's disease.

Nanobiotechnology is anticipated to experience substantial growth at a high compound annual growth rate (CAGR), propelled by the increasing approvals of nanomedicine and the introduction of advanced technology. Notably, theranostic nanoparticles have garnered attention for their ability to facilitate swift diagnosis and customize treatment options for multiple disorders simultaneously. The advantages of nanoparticles, such as low toxicity, smaller size, and chemical flexibility, prove beneficial in overcoming limitations associated with traditional routes of generic drug administration. Additionally, the field of tissue engineering and regenerative medicine commands a noteworthy share, supported by both government and private investments, substantial healthcare expenditure, and the presence of a significant number of established and emerging players. These factors are expected to propel growth in this segment throughout the forecast period.

By Application Analysis

The Health segment accounted for the highest market share during the forecast period.The growth of the segment is anticipated to be fueled by a rising disease burden, the expanding availability of agri-biotech and bio-services, and technological advancements in the bio-industrial sector. Moreover, substantial progress in machine learning, Artificial Intelligence (AI), and big data is expected to enhance the penetration of bioinformatics applications, particularly in industries like food and beverages, contributing further to the segment's growth. Furthermore, the market is expected to experience growth driven by collaborative efforts and partnerships focused on the development and commercialization of new therapeutic platforms and molecules. For instance, in January 2021, Novartis joined forces with Alnylam to explore the application of the latter's siRNA technology in developing targeted therapy for the restoration of liver function. Similarly, in September 2021, AstraZeneca and VaxEquity collaborated to develop and commercialize a self-amplifying RNA therapeutics platform, aiming to explore novel therapeutic programs. Additionally, the increasing demand for biosimilars and the expanding applications of precision medicine are anticipated to contribute to the growth of this segment during the forecast period.

Regional Insights

North America dominated the largest market in 2022.The growth of the regional market is driven by various factors, including the presence of key players, extensive research and development activities, and substantial healthcare expenditure. The region exhibits a notable penetration of genomics, proteomics, and cell biology-based platforms, thereby accelerating the adoption of life sciences tools. Additionally, the increasing prevalence of chronic diseases and the growing adoption of personalized medicine applications for treating life-threatening disorders are anticipated to have a positive impact on market growth in the region.

The Asia Pacific region is poised to exhibit the most rapid growth rate. This expansion can be attributed to increasing investments, enhancements in healthcare infrastructure, favorable government initiatives, and strategic expansion efforts by key market players. Notably, in February 2022, Moderna Inc. disclosed plans for a geographic expansion of its commercial network in Asia, establishing new subsidiaries in Malaysia, Singapore, Hong Kong, and Taiwan. Furthermore, collaborations in the biopharmaceutical sector, such as the strategic partnership between Kiniksa Pharmaceuticals and Huadong Medicine for the development and commercialization of Kiniksa's ARCALYST and mavrilimumab in the Asia-Pacific region, are expected to contribute significantly to the market's growth.

Key Market Players & Competitive Insights

The market is characterized by intense competition, with established players relying on advanced technology, high-quality products, and a strong brand image to drive revenue growth. These companies employ various strategies such as research and development, mergers and acquisitions, and technological innovations to expand their product portfolios and maintain a competitive edge in the market.

Recent Developments

• In May 2023, Gilead Sciences, Inc. announced the completion of its acquisition of XinThera, obtaining all outstanding shares. This strategic maneuver bolsters Gilead's clinical development goals by integrating complementary pipeline assets concentrated on validated targets in oncology and inflammation. By gaining access to a portfolio of small molecule inhibitors targeting PARP1 for oncology and MK2 for inflammatory diseases, Gilead reinforces its prominent position in the biotechnology industry.
• In January 2023, Gero and Pfizer have initiated a strategic research collaboration, leveraging Pfizer's domain expertise and Gero's advanced technology platform. This partnership is focused on uncovering genes and pathways linked to fibrotic diseases, representing a notable advancement in the biotechnology market. By combining the machine-learning capabilities of an innovative biotech firm with the resources of a prominent biopharmaceutical company, the collaboration aims to address chronic diseases and age-related conditions.
• In November 2022, AstraZeneca declared the inclusion of Neogene Therapeutics Inc. in its portfolio, both driven by the common objective of introducing cutting-edge cell therapies for patients grappling with solid tumors. Aligned in their commitment to advancing biotechnological approaches, the integration of TCR-Ts (cell therapy) from Neogene holds the potential to pinpoint intracellular targets, including cancer-specific mutations. This breakthrough offers new avenues for targeting markers that were previously inaccessible through cell therapies. The strategic collaboration holds significant promise in reshaping the landscape of cancer treatment and personalized medicine.
• In August 2022, Gilead Sciences, Inc. has completed a successful acquisition of MiroBio, securing access to their distinctive biotechnology discovery platform and extensive portfolio of immune inhibitory receptor agonists. The amalgamation of MiroBio's expertise in checkpoint receptor signaling and proprietary biotechnology techniques for producing exceptional agonist antibodies aligns seamlessly with Gilead's expertise in drug development and therapeutic areas. This marks a strategic advancement in the application of biotechnological innovations for the treatment of immune-related conditions.

Biotechnology Market Report Scope

Past Conference Report

Biotechnology 2023

The International “27^th Global Congress on Biotechnology” brings during a new spin on conferences by presenting the newest scientific improvements in your biotechnology field. This conference permits leading educational scientists, researchers and industrialists from everywhere the earth to exchange and share their experiences, recent innovations, sensible challenges, advanced instrumentation and analysis results. Biotechnology features a broader set of speakers, and a broader array of programs geared toward each scientists and industrialists. This meeting offers a strong likelihood to talk regarding the foremost recent advancements latest developments among the world.

Conference Series LLC Ltd is happy to welcome you to our “Biotechnology 2023” that has to be persisted in June 28-29, 2023 Held at Paris, France. This includes prompt keynote speakers and displays, Oral and Poster displays, and much tons of this additionally includes varied workshops guided by eminent delegates. The two-day meeting goes to be an occasion to seem forward to for its enlightening symposiums & workshops from established experts of the sector, exceptional keynote sessions directed by the simplest within the business.

Young Researchers Forum - Young Scientist Awards Biotechnology 2023

Young Research’s Awards at Biotechnology 2023 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation, only 25 presentations acceptable at the Biotechnology 2023 young research forum.

Young Scientist Benefits

Our conferences provide best Platform for your research through oral presentations.
Share the ideas with both eminent researchers and mentors.
Young Scientist Award reorganization certificate and memento to the winners
Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development
Award should motivate participants to strive to know their full potential, which could successively be beneficial to the world as whole.

Biotechnology 2023 could also be a world stage for exhibiting analysis regarding designation, hindrance and management and exchanging concepts regarding it and thru this fashion, adds to the unfold of knowledge in Biotechnology and child health for the advantage of each learned community and business. The organizing committee of the Biotechnology 2023 is preparing for associate energizing and instructive meeting program furthermore as comprehensive lectures, symposia, workshops on an expansion of topics, poster displays and various programs for participants from everywhere the earth. It will also convince be an excellent open door for the representatives from Universities and Institutes to cooperate with the planet class researchers and an impressive opportunity for businesses keen at expanding their global market reach. We tend to ask you to the Biotechnology 2023, where you will inform possess a serious experience with students from all round the world. All members of the commercial Biotechnology 2023, organizing committee expect to fulfil you in Paris, France.